Effect of MDR modulators verapamil and promethazine on gene expression levels of MDR1 and MRP1 in doxorubicin-resistant MCF-7 cells (Englisch)
- Neue Suche nach: Dönmez, Yaprak
- Neue Suche nach: Akhmetova, Laila
- Neue Suche nach: İşeri, Özlem Darcansoy
- Neue Suche nach: Kars, Meltem Demirel
- Neue Suche nach: Gündüz, Ufuk
- Neue Suche nach: Dönmez, Yaprak
- Neue Suche nach: Akhmetova, Laila
- Neue Suche nach: İşeri, Özlem Darcansoy
- Neue Suche nach: Kars, Meltem Demirel
- Neue Suche nach: Gündüz, Ufuk
In:
Cancer Chemotherapy and Pharmacology
;
67
, 4
; 823-828
;
2010
-
ISSN:
- Aufsatz (Zeitschrift) / Elektronische Ressource
-
Titel:Effect of MDR modulators verapamil and promethazine on gene expression levels of MDR1 and MRP1 in doxorubicin-resistant MCF-7 cells
-
Beteiligte:Dönmez, Yaprak ( Autor:in ) / Akhmetova, Laila ( Autor:in ) / İşeri, Özlem Darcansoy ( Autor:in ) / Kars, Meltem Demirel ( Autor:in ) / Gündüz, Ufuk ( Autor:in )
-
Erschienen in:Cancer Chemotherapy and Pharmacology ; 67, 4 ; 823-828
-
Verlag:
- Neue Suche nach: Springer-Verlag
- Neue Suche nach: Springer
-
Erscheinungsort:Berlin
-
Erscheinungsdatum:2010
-
ISSN:
-
ZDBID:
-
DOI:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Elektronische Ressource
-
Sprache:Englisch
- Neue Suche nach: 44.40 / 44.38
- Weitere Informationen zu Basisklassifikation
-
Schlagwörter:
-
Klassifikation:
-
Datenquelle:
Inhaltsverzeichnis – Band 67, Ausgabe 4
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 729
-
Statins are logical candidates for overcoming limitations of targeting therapies on malignancy: their potential application to gastrointestinal cancersShimoyama, Shouji et al. | 2011
- 741
-
Preclinical anti-tumor activity of antibody-targeted chemotherapy with CMC-544 (inotuzumab ozogamicin), a CD22-specific immunoconjugate of calicheamicin, compared with non-targeted combination chemotherapy with CVP or CHOPDiJoseph, John F. / Dougher, Maureen M. / Evans, Deborah Y. / Zhou, Bin-Bing / Damle, Nitin K. et al. | 2010
- 751
-
A phase I open-label study evaluating the cardiovascular safety of sorafenib in patients with advanced cancerTolcher, Anthony W. / Appleman, Leonard J. / Shapiro, Geoffrey I. / Mita, Alain C. / Cihon, Frank / Mazzu, Arthur / Sundaresan, Pavur R. et al. | 2010
- 765
-
Effective clearance of Ara-U the major metabolite of cytosine arabinoside (Ara-C) by hemodialysis in a patient with lymphoma and end-stage renal failureRadeski, Dejan / Cull, Gavin M. / Cain, Michael / Hackett, L. Peter / Ilett, Kenneth F. et al. | 2010
- 769
-
Renal safety and efficacy of cisplatin-based chemotherapy in patients with a solitary kidney after nephroureterectomy for urothelial carcinoma of the upper urinary tractCho, Kang Su / Joung, Jae Young / Seo, Ho Kyung / Cho, In-Chang / Chung, Han Soo / Chung, Jinsoo / Lee, Kang Hyun et al. | 2010
- 775
-
Biodistribution of PVP-hypericin and hexaminolevulinate-induced PpIX in normal and orthotopic tumor-bearing rat urinary bladderVandepitte, Joachim / Van Cleynenbreugel, Ben / Hettinger, Klaudia / Van Poppel, Hendrik / de Witte, Peter A. M. et al. | 2010
- 783
-
Lack of effect of casopitant on the pharmacokinetics of docetaxel in patients with cancerDandamudi, Uday B. / Adams, Laurel M. / Johnson, Brendan / Bauman, John / Morris, Shannon / Murray, Sharon / Webb, R. Timothy / Gartner, Elaina / Hohl, Raymond / Lewis, Lionel D. et al. | 2010
- 791
-
Phase II study of S-1, a novel oral fluoropyrimidine, and biweekly administration of docetaxel for previously treated advanced non-small-cell lung cancerOki, Yasunari / Hirose, Takashi / Yamaoka, Toshimitsu / Kusumoto, Sojiro / Shirai, Takao / Sugiyama, Tomohide / Okuda, Kentaro / Nakashima, Masanao / Murata, Yasunori / Ohmori, Tohru et al. | 2010
- 799
-
Beta-elemene inhibits melanoma growth and metastasis via suppressing vascular endothelial growth factor-mediated angiogenesisChen, Wenxing / Lu, Yin / Wu, Jiaming / Gao, Ming / Wang, Aiyun / Xu, Bo et al. | 2010
- 809
-
Plasma and cerebrospinal fluid pharmacokinetics of MP470 in non-human primatesBaxter, P. A. / Thompson, P. A. / McGuffey, L. M. / Gibson, B. W. / Dauser, R. C. / Nuchtern, J. G. / Shi, C. / Inloes, R. / Choy, G. / Redkar, S. et al. | 2010
- 813
-
Solamargine, a steroidal alkaloid glycoside, induces oncosis in human K562 leukemia and squamous cell carcinoma KB cellsSun, Lingmei / Zhao, Ying / Yuan, Huiqing / Li, Xia / Cheng, Aixia / Lou, Hongxiang et al. | 2010
- 823
-
Effect of MDR modulators verapamil and promethazine on gene expression levels of MDR1 and MRP1 in doxorubicin-resistant MCF-7 cellsDönmez, Yaprak / Akhmetova, Laila / İşeri, Özlem Darcansoy / Kars, Meltem Demirel / Gündüz, Ufuk et al. | 2010
- 829
-
Second-line chemotherapy for advanced or recurrent endometrial carcinoma previously treated with paclitaxel and carboplatin, with or without epirubicinUeda, Yutaka / Miyake, Takahito / Egawa-Takata, Tomomi / Miyatake, Takashi / Matsuzaki, Shinya / Yokoyama, Takuhei / Yoshino, Kiyoshi / Fujita, Masami / Enomoto, Takayuki / Kimura, Tadashi et al. | 2010
- 837
-
Phase I clinical trial of the anti-EGFR monoclonal antibody nimotuzumab with concurrent external thoracic radiotherapy in Canadian patients diagnosed with stage IIb, III or IV non-small cell lung cancer unsuitable for radical therapyBebb, Gwyn / Smith, Colum / Rorke, Stewart / Boland, William / Nicacio, Leonardo / Sukhoo, Ryan / Brade, Anthony et al. | 2010
- 847
-
Prognostic factors in patients with advanced biliary tract cancer receiving chemotherapySasaki, Takashi / Isayama, Hiroyuki / Nakai, Yousuke / Togawa, Osamu / Kogure, Hirofumi / Ito, Yukiko / Yamamoto, Keisuke / Mizuno, Suguru / Yagioka, Hiroshi / Yashima, Yoko et al. | 2010
- 855
-
BACPTDP: a water-soluble camptothecin pro-drug with enhanced activity in hypoxic/acidic tumorsAdams, David J. / Waud, William R. / Wani, Mansukh C. / Manikumar, Govindarajan / Flowers, James L. / Driscoll, Timothy A. / Morgan, Lee Roy et al. | 2010
- 867
-
Combinatorial effects of thymoquinone on the anti-cancer activity of doxorubicinEffenberger-Neidnicht, Katharina / Schobert, Rainer et al. | 2010
- 875
-
Population pharmacokinetics of clofarabine and its metabolite 6-ketoclofarabine in adult and pediatric patients with cancerBonate, Peter L. / Cunningham, Casey C. / Gaynon, Paul / Jeha, Sima / Kadota, Richard / Lam, Gilbert N. / Razzouk, Bassem / Rytting, Michael / Steinherz, Peter / Weitman, Steve et al. | 2010
- 891
-
A phase I study evaluating the role of the anti-epidermal growth factor receptor (EGFR) antibody cetuximab as a radiosensitizer with chemoradiation for locally advanced pancreatic cancerArnoletti, J. P. / Frolov, A. / Eloubeidi, M. / Keene, K. / Posey, J. / Wood, T. / Greeno, Edward / Jhala, N. / Varadarajulu, S. / Russo, S. et al. | 2010
- 899
-
2-Deoxy-d-glucose activates autophagy via endoplasmic reticulum stress rather than ATP depletionXi, Haibin / Kurtoglu, Metin / Liu, Huaping / Wangpaichitr, Medhi / You, Min / Liu, Xiongfei / Savaraj, Niramol / Lampidis, Theodore J. et al. | 2010
- 911
-
Predictive factors for the effectiveness of neoadjuvant chemotherapy and prognosis in triple-negative breast cancer patientsMasuda, Hiroko / Masuda, Norikazu / Kodama, Yoshinori / Ogawa, Masami / Karita, Michiko / Yamamura, Jun / Tsukuda, Kazunori / Doihara, Hiroyoshi / Miyoshi, Shinichiro / Mano, Masayuki et al. | 2010
- 919
-
Imatinib mesylate enhances the malignant behavior of human breast carcinoma cellsRappa, Germana / Anzanello, Fabio / Lorico, Aurelio et al. | 2010
- 927
-
A phase II study of the antisense oligonucleotide GTI-2040 plus docetaxel and prednisone as first-line treatment in castration-resistant prostate cancerSridhar, Srikala S. / Canil, Christina M. / Chi, Kim N. / Hotte, Sebastien J. / Ernst, Scott / Wang, Lisa / Chen, Eric X. / Juhasz, Agnes / Yen, Yun / Murray, Peter et al. | 2010
- 935
-
Cyclooxygenase-2 contributes to functional changes seen on experimental hemorrhagic cystitis induced by ifosfamide in rat urinary bladderMacedo, Francisco Y. B. / Mourão, Lívia T. C. / Palheta, Raimundo C. / Jucá, Davi M. / Lima, Roberto C. P. / de Sá C. Neto, José / Magalhães, Pedro J. C. / Santos, Armênio A. / Souza, Marcellus H. L. P. / Brito, Gerly A. C. et al. | 2010
- 945
-
Phase 1 study of MLN8054, a selective inhibitor of Aurora A kinase in patients with advanced solid tumorsDees, E. Claire / Infante, Jeffrey R. / Cohen, Roger B. / O’Neil, Bert H. / Jones, Suzanne / von Mehren, Margaret / Danaee, Hadi / Lee, Yih / Ecsedy, Jeffrey / Manfredi, Mark et al. | 2010
- 955
-
A phase I pharmacokinetics study of 9-nitrocamptothecin in patients with advanced solid tumorsYan, Zhao / Zhu, Zhongling / Li, Kai / Chen, Peng / Wang, Liuchun / Huang, Chun / Xue, Jinhuai / Liu, Meijun et al. | 2010
- 963
-
Pyridoxine to protect from oxaliplatin-induced neurotoxicity without compromising antitumour effectGarg, Madhu B. / Ackland, Stephen P. et al. | 2010
- 967
-
Durable remission after treatment with very low doses of imatinib for FIP1L1-PDGFRα-positive chronic eosinophilic leukaemiaHelbig, Grzegorz / Moskwa, Andrzej / Hus, Marek / Piszcz, Jarosław / Swiderska, Alina / Urbanowicz, Alina / Całbecka, Małgorzata / Seferyńska, Ilona / Raźny, Małgorzata / Rodzaj, Marek et al. | 2011